The Family Firm’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.46M Sell
20,077
-12,357
-38% -$1.41M 0.59% 40
2025
Q1
$3.28M Hold
32,434
0.73% 33
2024
Q4
$3M Hold
32,434
0.67% 32
2024
Q3
$3.13M Hold
32,434
0.69% 33
2024
Q2
$2.78M Buy
32,434
+6,202
+24% +$520K 0.62% 31
2024
Q1
$2.17M Buy
+26,232
New +$1.92M 0.53% 40

Other funds holding EHC

The Family Firm's EHC Position: Q2 2025 in Review

The Family Firm reduced its Encompass Health (EHC) stake by 38% in Q2 2025, selling an estimated $1.41M and leaving 20,077 shares worth $2.46M. The position accounts for 0.59% of the portfolio, ranked #40.

The Family Firm first reported a position in EHC in Q1 2024 and has held it in 6 quarters since. The position peaked at $3.28M in Q1 2025. 607 funds tracked by Wall St. Rank hold EHC as of Q2 2025.

  • The Family Firm held 20,077 shares of Encompass Health worth $2.46M as of Q2 2025.
  • The Family Firm sold 12,357 Encompass Health shares in Q2 2025, an estimated $1.41M.
  • Encompass Health made up 0.59% of The Family Firm's portfolio in Q2 2025, its #40 holding.
  • The Family Firm first reported a position in Encompass Health in Q1 2024 and has held it in 6 quarters since.
  • The Family Firm's Encompass Health position peaked at $3.28M in Q1 2025.
  • 607 funds tracked by Wall St. Rank held Encompass Health as of Q2 2025.

Based on The Family Firm's 13F filing for Q2 2025, filed 8 Aug 2025.